Featured Post from University of Delaware

Multi-sector partnership leads to first practical pilot of vehicle-to-grid power

Electric utility fleet of EVs will begin providing power to balance electric grid

Oct 3, 2024

4 min

Willett Kempton
CaptionResizeWrap TextRemove


A multi-pronged effort led by corporations, industry associations and an academic research institution has launched the first practical pilot project of “vehicle-to-grid” power (V2G) set up so that industrial participants can scale it at low cost.


Invented by the University of Delaware, V2G uses batteries in parked EVs to support the electric grid or to provide backup during power failures. This pilot is the first targeted toward large scale expansion, because it follows standards (by SAE and UL), uses production EVs (with UD modifications), complies with utility requirements, and qualifies for wholesale power markets. The pilot has been implemented by Delmarva Power (an Exelon Company), working with UD.


The project has set up an electric utility fleet of EVs to begin providing power to balance the electric grid, using Ford Mach-E EVs in the Delmarva Power fleet, and following new rules of the Federal Energy Regulatory Commission (FERC) for distributed energy resources. These Delmarva Power fleet vehicles are driving for utility operations during normal work schedule and provide wholesale grid services for PJM Interconnection when parked.


The cooperative effort was organized by Prof. Willett Kempton, originator of the V2G concept. Kempton said the resulting demonstration is significant because it shows a cost-effective pathway for standards based, regulatory-compliant, mass-manufactured V2G.


“Our close collaboration with Ford Motor, based on our joint Memorandum of Understanding, was very productive. Ford engineers’ advice helped us fully integrate the car’s CAN communications with LIN-CP,” Kempton said. “Ford already markets a production EV with home backup power, and they have a sophisticated understanding of potential EV synergies with the electric power grid. We hope that collaborations like this will also help OEMs like Ford to see a path to incorporation of these new standards and technologies into production EVs.”


The new standard for V2G signal definitions were finalized and approved just this year thanks to UD Research Professor Rodney McGee, Task Force Chair of the SAE standards development for J3400 (NACS) and J3068. (SAE was formerly called Society of Automotive Engineers.)


“These standards define the signaling to standardize low-cost AC charging, with all the functionality needed for safe operation of V2G and backup power from an EV. Both these standards implement a signaling method that is new to EV charging, called LIN-CP, yet is built from easy-to-implement automotive technologies,” McGee said.


UD’s MOU with Ford Motor Company allowed the two parties to cooperate on implementing sophisticated signaling for low-cost, high-functionality V2G. UD designed a retrofit package for proof of concept. The design was led by UD Postdoc Garrett Ejzak and used a bidirectional on-board charger and the new LIN-CP commands to make the Mach-E capable of sophisticated V2G. After testing at UD, the design was installed in four Delmarva Power fleet Mach-Es, to test these systems in a real-world fleet operating environment.


In addition to proving these new SAE standards, this project also shows that EVs can be high-value grid services providers to the electric system under the new FERC Order 2222 regulations. This new Federal rule enables small resources to collectively participate in electric markets to make the electric grid more reliable and more capable of incorporating fluctuating renewable power sources. PJM Interconnection, which manages the electric grid over 13 states, is participating under a Pilot Project agreement with the Delmarva Power demonstration, as an early proof of PJM’s new rules to meet FERC Order 2222 compliance.


“The use of virtual power plants, such as aggregations of electric vehicles, is an emerging resource type that can contribute to managing the energy transition by providing flexibility and other services needed to reliably operate the power grid,” said Scott Baker, Sr. Business Solution Analyst – Applied Innovation for PJM. “We look forward to working with Delmarva Power and the project team to test the technical capabilities of V2G electric vehicles and understand how this use case integrates with PJM’s new market construct for virtual power plants and DER Aggregators.”


Delmarva Power’s parent company, Exelon Corporation, is also a partner providing support for the project.


Project partner Nuvve Holding Corporation (Nuvve) updated their charging stations for full LIN-CP and V2G capabilities. Then project partner Delmarva Power installed four Nuvve charging stations at their facility in Newark, Delaware. The four individual Mach-Es are virtually combined into one V2G “power plant” by aggregation software from Nuvve Holdings. Nuvve CEO Gregory Poilasne described this:


“Our Nuvve charging stations now talk LIN-CP and implement the new SAE standards. This enables our GIVe aggregator software to tap high functionality V2G EVs,” Poilasne said. “By combining EVs as a single power resource, our technology is already serving as a “Distributed Energy Resource Aggregator” as specified by FERC Order 2222.”


The EVs’ performance and provision of grid services will be monitored over the next year by UD and Nuvve to provide documentation on their use both as fleet vehicles and as grid resources.

Connect with:
Willett Kempton

Willett Kempton

Professor, Marine Science and Policy

Prof. Kempton invented vehicle-to-grid power (V2G); he researches, publishes and lectures on offshore wind power and on electric vehicles.

Vehicle-to-Grid PowerOffshore Wind Policy

You might also like...

Check out some other posts from University of Delaware

1 min

From field to festival: How pumpkins grew into an autumn symbol

Type “Halloween” into your phone’s emoji search bar, and you’ll get three icons: a skull, a ghost, and a jack-o'-lantern. The skull and ghost make sense — but how did the pumpkin carve out such a starring role in our fall celebrations? Cindy Ott, associate professor of history and material culture at the University of Delaware, has the answer. She literally wrote the book on pumpkins, exploring how this humble orange gourd grew from a survival crop to a powerful symbol of American identity and nostalgia. Today, pumpkins dominate the fall season — from pumpkin pies and soups to the ever-popular pumpkin spice latte. Ott’s research uncovers how the pumpkin’s transformation from practical produce to cultural icon reflects broader shifts in American history, values, and traditions. To schedule an interview with Professor Ott, contact MediaRelations@udel.edu.

1 min

Soaring gold prices could bring big rewards – and even bigger risks

This week, gold prices surged to record highs, reshaping both the financial and geopolitical landscape. The University of Delaware’s Saleem Ali can explain the potential environmental, social and economic ripple effects of this gold rush and the opportunities and risks it creates. He says a controlled release of global gold reserves could help ease market pressure and mitigate the negative impacts. Ali, a professor of energy and the environment, can discuss the following main points: • The record gold price (which dipped slightly today) has implications for new gold mining projects becoming more financially attractive which could have environmental and social implications in those areas. • Major gold trading hubs like Switzerland and Dubai will need to be more vigilant as gold will become more attractive for the illicit economy for commodities. • We have major global bank reserves of gold even though the gold standard is no longer used to back currency. Some of these reserves could be liquidated to reduce pressure and negative externalities. Such a controlled release of gold reserves could help to manage the price rise. Ali also serves on the Independent Governance Committee for the Dubai Multicommodity Center, which manages all of the gold coming into the United Arab Emirates. To reach Ali directly and arrange an interview, visit his profile and click on the “connect” button. Interested reporters can also send an email to MediaRelations@udel.edu.

6 min

Taking discoveries to the real world for the benefit of human health

It takes about a decade and a lot of money to bring a new drug to market—between $1 billion to $2 billion, in fact. University of Delaware inventor Jason Gleghorn wants to change that. At UD, Gleghorn is developing leading-edge microfluidic tissue models. The devices are about the size of two postage stamps, and they offer a faster, less-expensive way to study disease and to develop pharmaceutical targets. These aren’t tools he wants to keep just for himself. No, Gleghorn wants to put the patented technology he’s developing in the hands of other experts, to advance clinical solutions in women’s health, maternal-fetal health and pre-term birth. His work also has the potential to improve understanding of drug transport in the female reproductive tract, placenta, lung and lymph nodes. Gleghorn, an associate professor of biomedical engineering, was named to the first cohort of Innovation Ambassadors at UD, as part of the University’s effort to foster and support an innovation culture on campus. Below, he shares some of what he’s learned about translating research to society. Q: What is the problem that you are trying to address? Gleghorn: A lot of disease has to do with disorganization in the body’s normal tissue structure. My lab makes microfluidic tissue models, called organ-on-a-chip models, that have super-tiny channels about the thickness of a human hair, where we can introduce very small amounts of liquid, including cells, to represent an organ in the human body. This can help us study and understand the mechanism of how things work in the body (the biology) or help us do things like drug screening to test therapeutic compounds for treating disease. And while these little microfluidic devices can do promising things, the infrastructure required to make the system work often restricts their use to high-end labs. We want to democratize the techniques and technology so that nonexperts can use it. To achieve this, we changed the way we make these devices, so that they are compatible with standard manufacturing, which means we can scale them and create them much easier. Gleghorn: One of the problems with drug screening, in general, is that animal model studies don’t always represent human biology. So, when we’re using animal models to test new drugs — which have been the best tool we have available — the results are not always apples to apples. Fundamentally, our microfluidic devices can model what happens in humans … we can plug in the relevant human components to understand how the mechanism is working and then ask questions about what drives those processes and identify targets for therapies to prevent the dysfunction. Q: What is innovative about this device? Gleghorn: The innovation part is this modularity — no one makes these devices this way. The science happens on the tiny tissue model insert, which is sandwiched between two pieces of clear acrylic. This allows us to watch what’s happening on the tissue model insert in real time. Meanwhile, the outer shell’s clamshell design provides flexibility: if we’re studying lung tissue and we want to study the female reproductive tract, all we do is unscrew the outer shell and insert the proper tissue model that mimics the female reproductive tract and we’re off. We’ve done a lot of the engineering to make it very simple to operate and use, and adaptable to common lab tools that everyone has, to eliminate the need for financial investment in things like specialized clean rooms, incubators and pumps, etc., so the technology can be useful in regular labs or easily deployable to far-flung locations or countries. With a laser cutter and $500 worth of equipment, you could conceivably mass manufacture these things for maternal medicine in Africa, for example. Democratizing the technology so it is compatible and useful for even an inexperienced user aligns with the mission of my lab, which focuses on scaling the science and the innovation faster, instead of only a few specialized labs being a bottleneck to uncovering new mechanisms of disease and the development of therapies. We patented this modularity, the way to build these tiny microfluidic devices and the simplicity of how it's used as a tool set, through UD’s Office of Economic Innovation and Partnerships (OEIP). Q: How have you translated this work so far? Gleghorn: To date, we've taken this microfluidic system to nine different research labs across seven countries and four continents — including the United States, the United Kingdom, Australia, France, Belgium and South Africa. These labs are using our technology to study problems in women’s health and collecting data with it. We’re developing boot camps where researchers can come for two or three days to the University of Delaware, where we teach them how to use this device and they take some back with them. From a basic science perspective, there is high enthusiasm for the power of what it can tell you and its ease of use. As engineers, we think it's pretty cool that many other people are using our innovations for new discoveries. Q: What support and guidance have you received from the UD innovation ecosystem? Gleghorn: To do any of this work, you need partners that have various expertise and backgrounds. UD’s Office of Economic Innovation and Partnerships has built a strong team of professionals with expertise in different areas, such as how do you license or take something to patent, how do you make connections with the business community? OEIP is home to Delaware’s Small Business Development Center, which can help you think about business visibility in terms of startups. Horn Entrepreneurship has built out impressive programs for teaching students and faculty to think entrepreneurially and build mentor networks, while programs like the Institute for Engineering Driven Health and the NSF Accelerating Research Translation at UD provide gap funding to be able to do product development and to take the work from basic prototype to something that is more marketable. More broadly in Delaware is the Small Business Administration, the Delaware Innovation Space and regional grant programs and small accelerators to help Delaware innovators. Q: How have students in your lab benefited from engaging in innovation? Gleghorn: Undergraduate students in my lab have made hundreds of these devices at scale. We basically built a little manufacturing facility, so we have ways to sterilize them, track batches, etc. We call it “the foundry.” In other work, graduate students are engineering different components or working on specific system designs for various studies. The students see collaborators use these devices to discover new science and new discoveries. That's very rewarding as an engineer. Additionally, my lab focuses on building solutions that are useful in the clinic and commercially viable. As a result, we've had two grad students spin out companies related to the work we've been doing in the lab. Q: How has research translation positively impacted your work? Gleghorn: I started down this road maybe five years ago, seriously trying to think about how to translate our research findings. Being an entrepreneur, translating technology — it's a very different way to think about your work. And so that framework has really permeated most of the research that I do now and changed the way I think about problems. It has opened new opportunities for collaboration and for alternate sources of funding with companies. This has value in terms of taking the research that you're doing fundamentally and creating a measurable impact in the community, but it also diversifies your funding streams to work on important problems. And different viewpoints help you look at the work you do in new ways, challenging you to define the value proposition, the impact of your work.

View all posts
Powered by